======= PLEKHA2 ======= == Gene Information == * **Official Symbol**: PLEKHA2 * **Official Name**: pleckstrin homology domain containing A2 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=59339|59339]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9HB19|Q9HB19]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PLEKHA2&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PLEKHA2|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607773|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Binds specifically to phosphatidylinositol 3,4- diphosphate (PtdIns3,4P2), but not to other phosphoinositides. May recruit other proteins to the plasma membrane (By similarity). {ECO:0000250}. |PH| |laminin binding| |fibronectin binding| |phosphatidylinositol-3,4-bisphosphate binding| |positive regulation of cell-matrix adhesion| |PDZ domain binding| |phosphatidylinositol biosynthetic process| |regulation of cell-matrix adhesion| |positive regulation of cell-substrate adhesion| |phosphatidylinositol metabolic process| |glycerophospholipid biosynthetic process| |regulation of cell-substrate adhesion| |glycerolipid biosynthetic process| |phospholipid biosynthetic process| |glycerophospholipid metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |positive regulation of cell adhesion| |organophosphate biosynthetic process| |lipid biosynthetic process| |protein-containing complex| |regulation of cell adhesion| |organophosphate metabolic process| |cellular lipid metabolic process| |lipid metabolic process| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp292|Menadione 5μM R06 exp292]]|-3.45| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|-2.53| |[[:results:exp182|IU1-47 25μM R04 exp182]]|-2.44| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-2.39| |[[:results:exp143|Phenformin 20μM R03 exp143]]|-2.27| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|-2.18| |[[:results:exp446|4-Nitroquinoline-1-oxide 0.5μM R08 exp446]]|-2.03| |[[:results:exp211|AICAR 240μM R05 exp211]]|-2| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-2| |[[:results:exp455|Benzoate 10000μM R08 exp455]]|-1.88| |[[:results:exp492|iCRT14 30μM R08 exp492]]|-1.85| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-1.81| |[[:results:exp155|UNC1999 2μM R03 exp155]]|-1.75| |[[:results:exp42|BI-6727 0.001μM R01 exp42]]|-1.74| |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|-1.72| |[[:results:exp333|All-trans-Retinoic-Acid 8μM R07 exp333]]|-1.71| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|1.76| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|1.78| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|1.8| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|1.88| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|1.98| |[[:results:exp140|Nicotinate 1000μM R03 exp140]]|2.1| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|2.17| |[[:results:exp149|SB203580 25μM R03 exp149]]|2.17| |[[:results:exp375|Lenalidomide 20μM R07 exp375]]|2.36| |[[:results:exp504|MK2206 4μM R08 exp504]]|3.08| ^Gene^Correlation^ |[[:human genes:p:pten|PTEN]]|0.438| Global Fraction of Cell Lines Where Essential: N/A ^Tissue^Fraction Of Cell Lines Where Essential^ == Essentiality in NALM6 == * **Essentiality Rank**: 14572 * **Expression level (log2 read counts)**: 7.37 {{:chemogenomics:nalm6 dist.png?nolink |}}